Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

02/02/2018 03:00

Feb 2 (Reuters)-  
              Ono Pharmaceutical Co Ltd  
              CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)  
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          COMPANY    
                     RESULTS             RESULT          FORECAST    
  Sales              200.57              188.85           260.00     
                   (+6.2 pct)          (+68.0 pct)      (+6.2 pct)   
  Operating           52.19               53.30            54.50     
                   (-2.1 pct)         (+138.8 pct)      (-24.6 pct)  
  Pretax              55.33               56.19            57.50     
                   (-1.5 pct)         (+123.8 pct)      (-22.9 pct)  
  Net                 41.44               42.47            43.00     
                   (-2.4 pct)         (+121.4 pct)      (-22.9 pct)  
  EPS Basic         79.74 yen           80.13 yen        82.74 yen   
  EPS Diluted       79.74 yen           80.13 yen                    
  Ann Div                               40.00 yen        45.00 yen   
  -Q2 Div           25.00 yen           20.00 yen                    
  -Q4 Div                               20.00 yen        20.00 yen   
  
  NOTE - Ono Pharmaceutical Co Ltd.  
  (Figures are reported based on international accounting rules (IFRS).)  
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half  
  dividend and Q4 to the second-half dividend announced before a new corporate law in  
  2006 allowed companies to pay and report dividends on a quarterly basis. 
  *Net - represents Net profit attributable to owners of the parent company.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T  
  ((Tokyo Headline News Desk +813 6441 1812))